Evidence map›Paper›PMID 25976161›Full record

SynthesisPediatric blood & cancer2015

Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature.

Amanda M Brandow, Rebecca A Farley, Julie A Panepinto

Registry-linked trialOpen access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Pediatric blood & cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03899246 (Safety and Feasibility of High-Dose Topical Capsaicin for the Treatment of Neuropathic Pain in Pediatric Sickle Cell Disease), which is not on this map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03899246 phase1completednot on this mapstarted 2019, after this paper: background citation

Safety and Feasibility of High-Dose Topical Capsaicin for the Treatment of Neuropathic Pain in Pediatric Sickle Cell Disease

TypeinterventionalSponsorChildren's Hospital of MichiganRan2019 to 2020Enrolled10ConditionsNeuropathic Pain, Sickle Cell DiseaseArmsEight Percent Topical Capsaicin
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Optimizing the management of chronic pain in sickle cell disease.Hematology. American Society of Hematology. Education Program · 2020
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Amanda M BrandowSection of Pediatric Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Rebecca A FarleySection of Pediatric Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Julie A PanepintoSection of Pediatric Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Children's Hospital of Wisconsin · USMedical College of Wisconsin · US

Funding

Peripheral Sensitization as a Novel Mechanism for Pain in Sickle Cell DiseaseK23HL114636 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI BRANDOW, AMANDA M · 2013 to 2017
$752k
NHLBI NIH HHS 1 K23HL114636-01A1NHLBI NIH HHS K23 HL114636
6 · The paper itself

Abstract

Novel insights into the neurobiology of sickle cell disease (SCD) pain have recently been discovered. We systematically reviewed the literature focusing on original research that examined the biology of pain in SCD and/or addressed assessment or treatment of neuropathic pain in SCD. This review of 15 articles that met inclusion criteria provides epidemiological, basic, and clinical data that support central and/or peripheral nervous system abnormalities likely contribute to sickle cell pain. Continued basic and clinical investigation into pain neurobiology is imperative to translate these discoveries into novel ways to assess and treat neuropathic pain and decrease patient suffering.

Indexed as

Anemia, Sickle CellAnimalsCentral Nervous System SensitizationClinical Trials as TopicCross-Sectional StudiesDatabases, FactualDisease Models, AnimalForecastingHumansHyperalgesiaMiceModels, NeurologicalNeuralgiaPain ManagementPain MeasurementPeripheral Nervous Systemneurobiologyneuropathic painpainsickle cell disease

Identifiers

PMID25976161
PMCPMC4515148
OpenAlexW1582187353

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.